Table 1.
Baseline characteristics of 176 patients with primary MDS
| Characteristics | Total number |
|---|---|
| Age (ranged from 19 to 94 years, median 69 years) | |
| ≧65 years | 102 (58%) |
| <65 years | 74 (42%) |
| Gender | |
| Male | 121 (69%) |
| Female | 55 (31%) |
| FAB | |
| RA | 78 (44%) |
| RARS | 22 (13%) |
| RAEB | 76 (43%) |
| WHO 2016 | |
| MDS-SLD | 40 (23%) |
| MDS-MLD | 38 (22%) |
| MDS-RS-SLD | 13 (7%) |
| MDS-RS-MLD | 9 (5%) |
| MDS-EB1 | 32 (18%) |
| MDS-EB2 | 44 (25%) |
| IPSS-R (only 164 patients could be evaluated) | |
| Very low | 6 (4%) |
| Low | 54 (33%) |
| Intermediate | 41 (25%) |
| High | 35 (21%) |
| Very high | 28 (17%) |
FAB French-American-British classification, WHO World Health Organization, IPSS-R revised international prognostic scoring system, MDS myelodysplastic syndrome, SLD single lineage dysplasia, MLD multilineage dysplasia, RS ring sideroblasts, EB excess blasts